• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】31723

【品名】2-[3-(tert-butylamino)-2-hydroxypropoxy]-5-fluorobenzaldehyde

【CA登记号】

【 分 子 式 】C14H20FNO3

【 分 子 量 】269.3161432

【元素组成】C 62.44% H 7.49% F 7.05% N 5.2% O 17.82%

与该中间体有关的原料药合成路线共 1 条

合成路线1

该中间体在本合成路线中的序号:(V)

The reaction of 5-fluorosalicylaldehyde (I) with 1-chloro-3-(tert-butylamino)-2-propanol (II) by means of p-toluenesulfonic acid in refluxing benzene gives 5-chloromethyl-3-(tert-butyl)-2-(2-hydroxy-5-fluorophenyl)oxazolidine (III), which is cyclized again by treatment with NaH in hot DMF to afford 8-aza-4,9-dioxa-11-fluoro-8-(tert-butyl)-2,3-benzobicyclo[4.2.1]octan (IV). Hydrolysis of (IV) with aqueous 1N HCl at 80 C yields 1-(2-formyl-4-fluorophenoxy)-3-(tert-butylamino)-2-propanol (V), which is submitted to a Grignard reaction with propylmagnesium bromide (A) in refluxing ether to afford 1-[2-(1-hydroxybutyl)-4-fluorophenoxy]-3-(tert-butylamino)-2-propanol (VI). Finally, this compound is oxidized with chromic acid in acetone - H2SO4.

1 Demarne le Florence, H.; Compositions for treatment of cardiovascular conditions associated with overproduction of catecholamines. BE 0830766; CA 1052820; DE 2528147; FR 2276032; GB 1501632; JP 51023233; NL 7507703; US 4252825; US 4302601 .
2 Castaner, J.; Blancafort, P.; Serradell, M.N.; Neuman, M.; Butofilolol. Drugs Fut 1982, 7, 2, 96.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(A) 10970 (4R)-4-[3-(Benzyloxy)-4-methoxyphenyl]-2-pyrrolidinone C18H19NO3 详情 详情
(I) 31719 5-fluoro-2-hydroxybenzaldehyde C7H5FO2 详情 详情
(II) 31720 1-(tert-butylamino)-3-chloro-2-propanol C7H16ClNO 详情 详情
(III) 31721 2-[3-(tert-butyl)-5-(chloromethyl)-1,3-oxazolidin-2-yl]-4-fluorophenol C14H19ClFNO2 详情 详情
(IV) 31722 11-(tert-butyl)-4-fluoro-8,12-dioxa-11-azatricyclo[7.2.1.0(2,7)]dodeca-2,4,6-triene C13H16FNO2 详情 详情
(V) 31723 2-[3-(tert-butylamino)-2-hydroxypropoxy]-5-fluorobenzaldehyde C14H20FNO3 详情 详情
(VI) 31724 1-[2-[3-(tert-butylamino)-2-hydroxypropoxy]-5-fluorophenyl]-1-butanol C17H28FNO3 详情 详情
Extended Information